Key result
Transarterial Medtronic CoreValve System implantation in degenerated surgical bioprostheses achieved a 100% procedural success rate with 1 in-hospital death.
Why the study?
Is transarterial Medtronic CoreValve System implantation safe and effective in high-risk patients with degenerated surgically implanted aortic bioprostheses?
Observational (n=10)
Is transarterial Medtronic CoreValve System implantation safe and effective in high-risk patients with degenerated surgically implanted aortic bioprostheses?
Transarterial TAVI using the Medtronic CoreValve System is a feasible treatment option that provides hemodynamic and clinical improvement for high-risk patients with degenerated surgical aortic bioprostheses.
No takes yet. Share an insight, caveat, or question.
May support feasibility in high-risk patients; leaves open confirmation of safety and durability in larger studies.
Descoutures et al. (2011) conducted an observational in Degenerated surgically implanted aortic bioprostheses (n=10). Transarterial Medtronic CoreValve System implantation was evaluated on Procedural success. Transarterial Medtronic CoreValve System implantation in degenerated surgical bioprostheses achieved a 100% procedural success rate with 1 in-hospital death.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: